Title

Differential Regulation of Phosphokinases by Anti-HLA Class I and II Antibodies

Document Type

Conference Proceeding

Publication Date

2019

Publication Title

Am J Transplant

Abstract

Purpose: Anti-HLA Zantibodies, both pre-formed and de novo are associated with worse graft survival. Glomerular endothelial cells are the targets for antibody mediated rejection. We hypothesized that there are differences in the mechamsms of endothelial cell activation by of anti-HLA Zclass I and II antibodies. Also, this may explain differences in pathogenicity. Methods: Human primary renal glomerular endothelial cells (HRGEC) were HLA typed. Cells at passage 3-6, were stimulated with Gamma Interferon for 48hours. Cells were then exposed to sera with cell HLA specific anti-HLA Zclass I and II antibodies in separate experiments for a serial time period starting from 2 minutes to maximum of 120mmutes. Cell lysates were collected and studied for Phospho AKT and MAP Kinases by Western Blotting. Results: In these experiments, we demonstrate differential activation of phospho-kinases in the presence of anti-HLA Zclass I and class II antibodies. With anti-HLA Zclass I antibodies progressive activation of phospho AKT and MAP Kinases were noted beginning at 15 minutes [Figure la]. Anti-HLA Zclass II antibodies caused activation phospho AKT for 1 Ommutes beginning at 2 minutes, then activation was not seen till 60 minutes. MAPK were activated from 2-10 minutes with no further activation [Figure lb]. Conclusions: This differential activationmay lead to different downstream pathways that determine the endothelial cell susceptibility. Studies have shown that Phospho AKT activation promotes cell growth and prevents apoptosis. Continuous activation of pAKT by class I antibodies in contrast to class II antibodies may stimulate cell survival signals. Further studies on endothelial cell signaling pathways are needed to elucidate specific markers that are upregulated.

Volume

19

First Page

620

This document is currently not available here.

Share

COinS